Jamison Chung

How Will Health Care Regulators Address Artificial Intelligence?

How Will Health Care Regulators Address Artificial Intelligence?

Policymakers around the world are developing guidelines for use of artificial intelligence in health care.

Why Historic Landmarks Need Protection from Climate Change

Why Historic Landmarks Need Protection from Climate Change

Scholar argues that historic landmark preservation law must address the impact of climate change.

Combating AAPI Hate

Combating AAPI Hate

Scholars discuss ways to recognize and address anti-AAPI sentiment and policies.

Does Cosmetics Regulation Need a Makeover?

Does Cosmetics Regulation Need a Makeover?

Scholars reflect on the need for stronger regulatory oversight of cosmetics in the United States.

Regulating Organ Transplants and Donation

Regulating Organ Transplants and Donation

Experts explore how to improve organ transplantation practices in the United States.

The Regulation of Stolen Cultural Artifacts

The Regulation of Stolen Cultural Artifacts

Experts address weaknesses and inconsistencies in the U.S. regulation of looted cultural artifacts.

Maintaining the Regulatory Big Pitcher

Maintaining the Regulatory Big Pitcher

Scholars discuss beer regulations and the regulatory challenges facing the industry.

Facing Bias in Facial Recognition Technology

Facing Bias in Facial Recognition Technology

Experts advocate robust regulation of facial recognition technology to reduce discriminatory outcomes.

Vaccine Mandates in the Time of COVID-19

Vaccine Mandates in the Time of COVID-19

Experts examine the legality and efficacy of vaccine mandates.

Inside Insider Trading

Inside Insider Trading

Scholars propose regulatory and legislative changes to increase oversight of insider trading.

Paying College Athletes

Paying College Athletes

Regulatory reforms may provide student athletes with financial opportunities beyond scholarships.

Privacy Problems in the Genetic Testing Industry

Privacy Problems in the Genetic Testing Industry

Experts debate oversight of direct-to-consumer genetic tests and access to genetic information.